Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2019 Jan 1;104(1):74-82.
doi: 10.1210/jc.2018-01737.

Determination of Pubertal Status in Youths With Type 1 Diabetes Using Height Velocity and Trajectories

Affiliations

Determination of Pubertal Status in Youths With Type 1 Diabetes Using Height Velocity and Trajectories

Jia Zhu et al. J Clin Endocrinol Metab. .

Abstract

Context: Assessment of pubertal change is important for the management of chronic pediatric diseases, such as type 1 diabetes. Physical and/or laboratory assessments of pubertal status are often unavailable, impractical, or costly.

Objective: To develop and validate a practical and objective method to assess pubertal status using longitudinal linear growth in youths with type 1 diabetes.

Design, participants, and outcome measurements: Participants (n = 123) were part of a 2-year study assessing continuous glucose monitoring in youths with type 1 diabetes at a tertiary diabetes center. Pubertal status at visits was assigned by a tiered approach using clinical Tanner staging or indicators of pubertal maturation from the electronic medical record when available. For other visits, independent evaluations of height velocities and growth chart trajectories provided data for pubertal status assignments. Sensitivity analysis confirmed the validity of the pubertal status assignments.

Results: The sample (50% female, 95% white) had a mean ± SD age of 12.7 ± 2.7 years, diabetes duration of 6.0 ± 3.6 years, and hemoglobin A1c of 7.9 ± 0.8%. Of 985 study visits, 50% received a pubertal status assignment based on clinical Tanner staging, 29% on additional medical record review, and 22% on an evaluation of height velocity and growth chart trajectory. For the sensitivity analysis, pubertal status assignments based on height velocity and growth chart trajectory matched clinical Tanner staging in 87% of visits.

Conclusions: Our practical and objective method to assess pubertal status based on height velocity and growth chart trajectory highlights growth as a reliable and objective bioassay for pubertal onset, status, and progression.

PubMed Disclaimer

Figures

Figure 1.
Figure 1.
Growth curve example of growth trajectories during pubertal maturation, including height trajectories typically observed during prepubertal, pubertal, and postpubertal maturation in a female participant.
Figure 2.
Figure 2.
Growth curves illustrating discrepancies between pubertal status assignments by height velocity calculation and growth curve review. (a and b) A boy (a) and a girl (b) in whom the discrepancy is attributed to brief periods of seemingly irregular growth, likely due to errors in height measurements. (c and d) A boy (c) and a girl (d) in whom the discrepancy is attributed to transition periods between pubertal statuses. Arrows depict study visits without clinical Tanner staging that required pubertal status assignments by height velocity (HV) calculation and growth curve review. Pubertal status assignments by each method are shown in the tables for each growth curve, with “Adjudication Assignment” as the final pubertal status assigned after adjudication.

Similar articles

Cited by

References

    1. Amiel SA, Sherwin RS, Simonson DC, Lauritano AA, Tamborlane WV. Impaired insulin action in puberty: contributing factor to poor glycemic control in adolescents with diabetes. N Engl J Med. 1986;315(4):215–219. - PubMed
    1. Swan KL, Weinzimer SA, Dziura JD, Steil GM, Voskanyan GR, Steffen AT, Martin ML, Tamborlane WV. Effect of puberty on the pharmacodynamic and pharmacokinetic properties of insulin pump therapy in youth with type 1 diabetes. Diabetes Care. 2008;31(1):44–46. - PubMed
    1. Szadkowska A, Pietrzak I, Mianowska B, Bodalska-Lipińska J, Keenan HA, Toporowska-Kowalska E, Młynarski W, Bodalski J. Insulin sensitivity in Type 1 diabetic children and adolescents. Diabet Med. 2008;25(3):282–288. - PubMed
    1. Cemeroglu AP, Thomas JP, Zande LT, Nguyen NT, Wood MA, Kleis L, Davis AT. Basal and bolus insulin requirements in children, adolescents, and young adults with type 1 diabetes mellitus on continuous subcutaneous insulin infusion (CSII): effects of age and puberty. Endocr Pract. 2013;19(5):805–811. - PubMed
    1. Danne T, Phillip M, Buckingham B, Jarosz-Chobot P, Saboo B, Urakami T, Battelino T, Hanas R, Codner E; ISPAD Clinical Practice Consensus Guidelines 2018 Compendium. Insulin treatment in children and adolescents with diabetes. Pediatr Diabetes. 2018;19:115–135. - PubMed

Publication types